Annals of internal medicine
-
Letter Case Reports
JAK1/2 Inhibition in Severe TAFRO Syndrome: A Case Report.
-
Favresse J, Gillot C, Oliveira M, et al. Head-to-head comparison of rapid and automated antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Med. 2021;10:265. 33450853.
-
Comment
In CKD, the effect of dapagliflozin on kidney outcomes did not vary by T2DM status or CKD cause.
Wheeler DC, Stefánsson BV, Jongs N, et al. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9:22-31. 33338413.